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Abstract
Axonal injury close to cell bodies of motoneurons induces the death of the vast majority of
affected cells. Neurotrophic factors, such as brain derived neurotrophic factor (BDNF) and
glial cell derived neurotrophic factor (GDNF), delivered close to the damaged motor pool in a
non-regulated manner induce good survival of injured motoneurons and sprouting of their
axons but fail to induce functional reinnervation.
To avoid these  drawbacks of high levels of neurotrophic expression, we devised an  ex vivo
gene therapy system to induce transient expression of BDNF/GDNF in transfected rat adipose
tissue-derived stem cells (rASCs) which were grafted around the reimplanted ventral root,
embedded in collagen gel.
Strong BDNF/GDNF expression was induced in vitro in the first days after transfection with a
significant  decline  in  expression  10-14  days  following  transfection.  Numerous  axons  of
injured motoneurons were able to enter the reimplanted root following reimplantation and
BDNF or GDNF treatment  (192 ± 17 SEM vs 187 ± 12 SEM, respectively)  and produce
morphological  and  functional  reinnervation.  Treatment  with  a  combined  cell  population
(BDNF+GDNF-transfected rASCs) induced slightly improved reinnervation (247 ± 24 SEM).
In contrast, only few motoneurons regenerated their axons in control animals (63 ± 4 SEM)
which received untransfected cells.  The axons of surviving motoneurons showed elongative
growth typical of regenerative axons, without aberrant growth or coil formation of sprouting
axons.
These  findings  provide  evidence  that  damaged motoneurons  require  limited  and spatially
directed amounts of BDNF and GDNF to support their survival and regeneration. Moreover,
neurotrophic support appears to be needed only for a critical period of time not longer than for
two weeks after injury.
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Introduction
Plexus injuries in humans usually involve the avulsion of one or more ventral roots (Millesi
1992,  Bertelli and Ghizoni 2003, Gilbert et al. 2006).  Experimental ventral root avulsion in
animals mimics the features of proximal plexus lesions in humans, resulting in degeneration
and  later  loss  of  the  affected  motoneurons  in  the  ventral  horn  and  atrophy of  the  target
muscles (Koliatsos et al., 1994). Reimplantation of the avulsed ventral root in the spinal cord
increases  the  survival  rate  of  the  affected  motoneurons,  but  promotes  only  limited
reinnervation by the motor axons (Carlstedt et  al.  1986, 1993,  Nógrádi and Vrbová 1996,
2001, Eggers et al. 2010).
Several  attempts  have  been  made  to  improve  the  extent  of  reinnervation  by  surviving
motoneurons after ventral root avulsion and reimplantation. The use of riluzole (a compound
that blocks voltage-gated sodium and calcium channels and inhibits presynaptic glutamate
release) after experimental root avulsion and reimplantion of the L4 ventral root, dramatically
improved survival of injured motoneurons, accompanied by an extensive axonal regeneration
resulting in solid reinnervation  (up to 65%) of the target denervated muscles (Nógrádi and
Vrbová 2001, Nógrádi et al. 2007). Local application of recombinant GDNF, a member of the
transforming  growth  factor  beta  family  induced rescue  of  the  injured  motoneurons and
satisfactory reinnervation of the target  muscle  when applied in  co-treatment  with riluzole
(Bergerot et al. 2004). Other strategies involved the use of progenitor and stem cells in the
vicinity of the reimplanted ventral root (Hell et al. 2009, Su et al. 2009, Bonner et al. 2010).
Although satisfying survival of the injured motoneurons could be achieved, all these strategies
failed to induce functional regeneration of the target muscles.
Neurotrophic  factors  mediate  survival,  differentiation,  neurite  outgrowth  and  functional
plasticity  in  the  central  and  peripheral  nervous  system. In  vitro and  in  vivo experiments
confirm the promoting effects of neurotrophic factors (BDNF, NT3, NT4/5) on motoneuron
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survival (Henderson et al. 1993, Li et al 1994). The presence of messenger RNA coding for
neurotrophic  factors  at  appropriate  stages  in  spinal  cord  and  limb  bud  development  and
mRNA for their receptors on the motoneurons emphasize the high impact of neurotrophins in
a certain time windows of embryonic development of the spinal motoneurons (Henderson et
al. 1993).
GDNF and and other neurotrophic factors (BDNF, NT-3,NT-4/5) support motoneuron survival
under  several  experimental  conditions (Oppenheim  et  al.  1992,  Henderson  et  al.  1994,
Oppenheim et al.  1995,  Wu et  al.  1995, Vejsada et  al.  1995, 1998;  Kishino et  al.  1997,
Novikova et al. 1995, 1997, Wiese et al. 1999,  Boyd, JG. T. Gordon T. 2001).  On the other
hand, their use failed in the cases of promoting motoneuron axonal regeneration after avulsion
injuries.  Blits et al. (2004) injected GDNF-inducing Adeno-associated Virus (AAV) into the
injured spinal cord segment.  Although this treatment resulted in good motoneuron survival,
no functional reinnervation was achieved.  Similarly, the same group (Eggers et al. 2008) tried
to induce reinnervation of reimplanted ventral root and peripheral targets with direct injection
of  lentivirus  inducing  the  expression  of  GDNF  in  the  reimplanted  ventral  root,  without
success to induce elongative growth of the regenerating motor axons. The side effect of this
uncontrolled and persistent virus-based production of neurotrophic factors at the site of injury
was formation of irregular coils of sprouting axons, likely due to the so called “candy store”
trapping effect  of neurotrophic factors  on the injured axons.  Recent  efforts  to  establish a
gradient of neurotrophins along the injured sciatic nerve to force axons to grow along the
whole length of the nerve have proven unsuccessful. The likely reason for this could be that
even the lowest dose of viral constructs applied prohibited axonal growth and myelination of
the coil-forming axons (Eggers et al. 2013).
Based on the above data it can be hypothesized that by reducing the amount, duration and
location of neurotrophic factor overexpression after ventral root avulsion, the axons of injured
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motoneurons will be attracted to the site of neurotrophic factor application but will not be
trapped there. The aim of the present study is to establish conditions by applying non-viral
gene  therapy, enabling  regenerating  motor  axons  of  surviving  motoneurons  to  follow an
elongative growth pattern and reinnervate the denervated hind limb muscles.
Material and Methods
Isolation and culturing of rat adipose derived stem cells
Epididymal fat pads were isolated aseptically from male Sprague-Dawley rats under terminal
anaesthesia and transferred into 60 ml sterile PBS for further dissection. All subsequent steps
were carried out in a vertical laminar flow box to avoid infection.
The fat pads were cut into small pieces and blood vessels were removed. Tissue pieces were
washed twice with PBS followed by digestion in 10 ml of 1.5 mg/ml collagenase 1 solution
(Worthington Biochemical Co., Lakewood, NJ,  USA) for 30 min at  37°C and 180 U/min
shaking. The digested tissue was filtered through a 100 µm cell strainer and transferred into
50 ml Falcon tubes. Following centrifugation for 7 min  at  400g at room temperature,  the
supernatant was discarded and the pellets were washed by re-suspension and centrifugation
(400g, RT) in 1x PBS. The rASCs were re-suspended in 5ml rASC-medium (DMEM high
glucose, 1% Penicillin/Streptomycin, 1% glutamine, 10% fetal calf serum [FCS]) and brought
into  culture  in  75cm2 flasks.  Aliquots  of  1x106 cells/ml  in  DMEM (5% FCS)  with  10%
dimethylsulfoxide (DMSO) were made and stored in liquid nitrogen.
Frozen aliquots were thawed on 37°C before re-culturing and centrifuged for 5 min at 400g.
Cells were resuspended in fresh medium and sewn in 175ml flasks. After 24h the medium was
changed for further cultivation.
Cell staining with Cellbrite
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In order to track rASCs after transplantation, the cells were labelled using the CellbriteTM Red
Cytoplasmic Membrane Staining Kit (Biotium CA, USA).  The overall labelling efficacy was
approximately 95%.  Cells were trypsinized and suspended at a density of 1x106/ml in serum-
free DMEM. After adding 5µl of cell-labeling solution per 1ml of cell suspension, the cells
were incubated at 37° for 20 minutes. After a centrifugation step for 5 min at 1500 rpm at 37°,
the  supernatant  was  removed  and cells  were  gently resuspended in  warm (37°)  medium.
Following two more washing steps (centrifugation and resuspension), cells were resuspended
in serum free DMEM at a concentration of 1x106/ml for further in vivo use.
Design of pVAX1-rBDNF and pVAX1-mGDNF vectors
cDNA  sequences  for  rat  BDNF  and  mouse  GDNF  were  purchased  from  Open
Biosystems/Thermo Scientific (Pittsburgh, PA, USA). Both genes were amplified by using
Taq-polymerase. Primers were designed to introduce a Kozak translation initiation sequence
as well as specific restriction sites for further cloning into pVAX1 (Life Technologies, Paisley,
UK).  pVAX1  is  a  DNA  vaccination  plasmid  vector  designed  for  high-level  transient
expression. The resulting pVAX1-rBDNF and pVAX1-mGDNF plasmids (Fig. 1A-B) were
verified by sequencing and restriction digests.
Lipofectamine-based transfection of rASCs with pVAX1-rBDNF and pVAX1-mGDNF
Lipofectamine 2000 (Life  Technologies,  Paisley, UK),  a  liposomal  transfection agent  was
used  for  transient  transfection  in  this  study.   Rat  ASCs  were  plated  at  a  density  of
approximately 28,000 cells/cm2 in 24 well plates and transfected at a density of approx. 80%
with pVAX1_mGDNF or pVAX1_rBDNF.  Formation of micro particles took place in serum-
free DMEM high glucose to exclude interference of FCS with Lipofectamine 2000. Medium
was changed 4 hours after transfection to reduce cytotoxic effects of cationic liposomes. The
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DNA: Lipofectamine 2000 ratio of 1:1 was chosen in order to achieve maximum transfection
rate at low cytotoxicity, based on our previous experience (data not shown).
Evaluation of transgene expression: Enzyme linked immuno-sorbent assay (ELISA)
The expression kinetics of therapeutic transgenes were evaluated by the ELISA technique
(Boster  Biological  Technology  Ltd,  Fremont,  CA,  USA).  BDNF  or  GDNF  polyclonal
antibodies  were  used  to  pre-coat  96-well  plates  and  biotinylated  monoclonal  secondary
antibodies were applied. Antibody binding was visualized by using avidin-biotin-peroxidase
complexes  by  subsequent  adding  3,3´,5,5´-Tetramethylbenzidine  (TMB).  Medium  was
removed 24 hours prior to sampling and 500µl of fresh rASC-medium was added. According
to the manufacturer’s instructions supernatants were sampled and stored at -20°C for further
analysis with ELISA. Assuming a low target protein concentration 1:2 dilutions were prepared
and for each ELISA an individual standard curve was prepared. Number of experiments = 4,
number of replicates = 6. 
Biological activity assay
Rat embryos (12.5 days old) were removed from pregnant females (n=2) under deep terminal
ketamine-xylasine anaesthesia and rinsed in fresh Hanks' medium. The thoracic and lumbar
dorsal root ganglia (DRG) were carefully dissected and explanted onto Petri dishes filled with
medium and incubated with conditioned supernatants of transfected and untransfected rASCs
(n=4 for each group), respectively. The supernatants were taken 24 h after transfection of
rASCs with pVAX1-rBDNF and pVAX1-mGDNF and stored at -70 °C until further use. The
amount  of  neurotrophic  factors  in  the  supernatant  was  determined  by  using  the  ELISA
technique and the working concentrations were set to 5 ng/ml. After 24 h incubation with the
supernatants the DRGs were carefully washed and photographed under the microscope by
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using  an  Olympus  DP70  digital  camera  (Olympus  Ltd,  Tokyo,  Japan).   The  extent  of
longitudinal neurite outgrowth was determined  in each experimental group  through the use
of the Image J (NIH) image analysis program.
Ventral root avulsion-reimplantation and transplantation of rASC cells
All  together  48  female  Sprague-Dawley  rats  (Animal  Research  Laboratories,  Himberg,
Austria, and Animal Facilities at the Faculty of Medicine, University of Szeged, weighing
180-220 g body weight, average age 6 weeks) were used. Twenty-four animals were used for
short-term survival studies (5 and 10 days of survival, 4 animals in each group, except control
group), 15 rats survived for 3 months following the original operation (n=5 in each group) and
4 intact animals were used to determine the number of motoneurons in the intact L4 segment.
All  the  operations  were  carried  out  under  deep  ketamine-xylazine  anaesthesia  (ketamine
hydrochloride: 90 mg/kg body weight, Ketavet, Pharmacia & Upjohn Co.; xylazine: 5 mg/kg
body weight, Rompun, Bayer Co.) and sterile precautions. To maintain the body temperature
at 37.0±0.5°C, the rats were kept on a heating pad during the surgery.  Laminectomy was
performed at the level of T13–L1 vertebrae, the dura was opened and the left L4 ventral root
was pulled out leaving the dorsal roots intact. Then the cut end of the ventral root was inserted
into the lateral part of the spinal cord. To avoid damage to the cord, a small hole was created
on the lateral surface of the cord, and the avulsed root was inserted into the hole using a
watchmaker’s forceps (Dumont, Switzerland, No. 5). Special care was taken to avoid damage
to  the  cord,  including  its  motoneuron  pool,  or  to  the  reimplanted  root  (Fig.  1C).  The
reimplanted root was surrounded by stem cells (3 x 105) mixed in 10µl of 2.5mg/ml collagen
solution along a 3 mm length of the root (type 1, Sigma Aldrich). Animals in group 1 served
as controls: their L4 ventral root was avulsed and reimplanted and they received untransfected
rASCs.  In  group  2  animals  the  reimplanted  root  was  surrounded  by 3  x  105 stem cells
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transfected  with  pVAX1_mGDNF  (GDNF-rASC).   Group  3  animals  received  stem cells
transfected with pVAX1_rBDNF (BDNF-rASC) while group 4 animals received a mixed stem
cell population composed of equal numbers of BDNF- and GDNF-rASCs (GDNF+BDNF-
rASC; total number of cells was 3 x 105). The spinal cord was covered with the remaining
dura, the wound was closed and the animals were allowed to recover (Pajenda et al. 2013).
Animals were sacrificed 10 days or 3 months after the primary operation.  The experiments
were carried out with the approval of the Animal Protocol Review Board of City Government
of Vienna and with that of the Committee for Animal Experiments, University of Szeged and
rules regarding the care and use of animals for experimental procedures were followed. All
the procedures  were carried out  according to  the Helsinki  Declaration  on Animal  Rights.
Adequate care was taken to minimize pain and discomfort.
Retrograde labelling 
Operated animals that survived for 3 months (n=5 in each group) and intact animals (n=4)
were deeply reanaesthetized as described above. On the left side the ventral ramus of the L4
spinal nerve was sectioned and the proximal stump of the nerve covered (Fig. 1D) with few
crystals of Fast Blue (FB, Illing Plastics GmbH, Breuberg, Germany).  Five days after the
application  of  the  fluorescent  dye  the  animals  were  reanaesthetized  and  perfused
transcardially with 4% paraformaldehyde in 0.1 M phosphate buffer (pH=7.4).
Immunohistochemistry
Twenty-five  µm  thick  transverse  spinal  cord  sections  and  twenty  µm  thick  longitudinal
sections of the operated roots were cut on a cryostat (Leica CM1850, Leica GmbH, Germany)
and mounted onto gelatin-coated glass slides. Nonspecific binding sites were subsequently
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blocked with 1% milk powder solution. Primary antibodies were incubated overnight at 4 °C,
washed, and then incubated with fluorescent-conjugated secondary antibodies for 1 h at room
temperature.  The  following  primary  antibodies  were  used:  chicken  polyclonal  anti-green
fluorescent protein, (GFP, Merck-Millipore, 1:2000)  BDNF and GDNF, respectively, (both
from Abcam Ltd, Cambridge, UK, 1:100), anti-neurofilament 200kD (NF200, Abcam Ltd,
Cambridge, UK, 1:200). Secondary antibodies were used as follows: Alexa Fluor 488 goat
anti-chicken, Alexa Fluor 594 donkey anti-rat, Alexa Fluor 546 rabbit anti-mouse, Alexa Fluor
405 goat anti-rabbit (all from Life Technologies Corporation, 1:400). Sections processed for
choline-acetyltransferase  (ChAT)  immunohistochemistry  were  preincubated  in  3% normal
goat  serum for  1  h,  then  treated  with  a  polyclonal  goat  anti-ChAT antibody (Millipore-
Chemicon, Hofheim, Germany, 1:100) overnight at 4◦C. The immune reaction was completed
by using  the  avidin-biotin  technique  (reagents  were  purchased  from Vector  Laboratories,
Burlingame,  CA),  and ﬁnally were tyramide-ampliﬁed with the Alexa Fluor  546 TSA kit
(Tyramide Signal Ampliﬁcation; Life Technologies). Fluorescent signals were detected in an
Olympus FX51 epifluorescence microscope equipped with a DP70 digital camera (Olympus
Ltd,  Tokyo,  Japan).  Confocal  microscopic  images  were  obtained  by  using  an  Olympus
FluoView®  FV10i  compact  confocal  microscope.  Digital  images  were  resized  and  their
contrast and brightness were adjusted.
Cell counts
The number of retrogradely labelled and ChAT positive cells was determined (Fig. 1E). To
avoid  double  counting  of  the  same  neuron  present  in  two  consecutive  sections,  the
retrogradely labelled neurons were mapped with the aid of an Olympus (Olympus Ltd, Tokyo,
Japan) drawing tube, and their locations were compared to those of labelled neurones in the
previous section (Nógrádi et al. 2007, Pintér et al. 2010). The proportion of FB+/ChAT+ cells
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was determined in each experimental group. All sections from the L4 motoneurone pool were
used.
Analysis of locomotion pattern – CatWalk gait analysis
To determine and analyze the parameters of the hind limb movement pattern, the 'CatWalk'
automated quantitative gait analysis system was used (Noldus Ltd, version 7.1; Wageningen,
The Netherlands). Animals were pre-trained once one week before surgery and the cumulative
pre-training values representing the parameters of intact animals are included in the diagrams.
This computer-assisted method of locomotor analysis made it possible to quantify several gait
parameters, including duration and speed of different phases of the step cycle and print areas
detected during locomotion length (Hamers et  al.,  2001, 2006).  The following parameters
were taken into account during the analysis:
max. contact area  (expressed in mm2): The maximal contact area describes the paw area
contacted at the moment of maximal paw-floor contact during the stance phase.
the print area (expressed in mm2): total ﬂoor area contacted by the paw during the stance
phase.
the mean print  intensity (expressed in  arbitrary units):  the  mean pressure exerted  by one
individual paw during the floor contact.
the stance duration (expressed in s): the stance duration is the time of the stance phase.
the step cycle duration (expressed in s): It represents the time between two consecutive paw
placements (stance + swing duration).
Statistical analysis
The t-test and the two-way measurement analysis of variance (ANOVA) computed by using
Tukey’s all pair-wise multiple comparison procedures or Bonferroni's post hoc test, were used
to compare the group data.  Non-parametric data were analysed through the use of Mann-
Whitney U test. The various tests were used according to the nature of the data.
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Results
In vitro analysis of gene expression 
The rASCs transfected with either pVAX-rBDNF or pVAX-mGDNF were kept in culture and
supernatants were analyzed through the use of ELISA for their BDNF/GDNF content. Figure
2 shows that the plasmids were able to induce the required time course pattern of protein
production: both neurotrophin levels peaked few days after transfection (72h for BDNF and
48h for GDNF, Fig. 2) and expression dropped below the 24h levels by 9 days in culture.  
These data may suggest that both neurotrophic factors are produced in considerable amounts
for approximately 7 days, i.e. during the critical period of motoneuron survival after avulsion
injury (Koliatsos 1994, Nógrádi  et  al.  2007).   The  neurotrophic factors expression levels,
however, displayed differing time course: while BDNF was shown to have a peak expression
level  at  400% relative  to  the  24h  values  and declined  by 9  days,  GDNF levels  reached
approximately  250%  and  dropped  back  considerably  by  9  days,  this  level  of  protein
expression was maintained till the end of the time-course study (Fig. 2).  Considering absolute
values,  GDNF   expression  was  always  considerably  greater  than  that  of  BDNF.
Untransfected cells produced negligible amounts of GDNF or BDNF.
Analysis of in vitro biological activity of transfected rASCs
In order to prove that the transfected cells produced biologically potent neurotrophic factors,
we performed an in vitro essay.  Embryonic dorsal root ganglia were treated with supernatants
of BDNF- or GDNF-producing rASCs and their effects  was investigated after 24h.  Both
BDNF  and  GDNF  induced  an  approximately  twofold  longitudinal  neurite  outgrowth
compared  with  the  control  ganglia  that  received  supernatant  of  untransfected  rASCs.
Interestingly,  co-treatment  with  both  BDNF  and  GDNF,  but  with  identical  cumulative
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neurotrophic factor levels as in the cases of individual treatments did not result in improved
neurite outgrowth (Fig. 3).
General observations, functional improvement, CatWalk gait analysis system
Behavioral  analysis  was  started  2  weeks  after  surgery  and  the  first  signs  of  functional
recovery were observed 4-5 weeks after reimplantation of the ventral root.  Control (group 1,
treatment with untransfected rASCs) showed minimal improvement, i.e. their affected hind
limb was placed laterally with minimal dorsiflexion of the ankle joint and the spreading reflex
was negligible or completely missing.  In contrast,  animals that received transfected rASC
grafts around the reimplanted L4 ventral root (groups 2-4) developed an improving movement
pattern  similar  to  that  of  the  intact  hind limb.   Movements  of  the  ankle joint,  especially
dorsiflexion was extensive and toe spreading was present.  Quantitative gait analysis obtained
from the  CatWalk  automated  gait  analysis  system showed that  the  earliest  differences  in
functional recovery between these groups appear from week 6 and these differences became
significant by week 8 (Fig. 4).  Improved footprint parameters (max. contact area, print area,
mean intensity) and dynamic parameters characteristic of the step cycle (stance duration and
step cycle duration) showed improved movement pattern in groups 2-4 animals (Fig 4).
Interestingly,  animals  that  received  combined  rASC  (BDNF+GDNF)  grafts  (group  4)
displayed only slightly, but not significantly better footprint (max. contact area and print area)
parameters than the animals treated with either GDNF or BDNF (groups 2 and 3).
Localization of BDNF- and GDNF-transfected cells around the reimplanted ventral root
Rats  that  received  transfected  rASCs  embedded  in  collagen  matrix  placed  along  the
reimplanted ventral root, formed a well-defined tissue cuff around the reimplanted ventral
root 10 days after grafting (Fig. 5).  The majority of the grafted rASCs were labelled with
CellBrite  (Fig.  5A-B  and  F-G)  and  expressed  GDNF  (Fig.  5D-E)  or  BDNF  (Fig.  5I-J),
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respectively.  None of the grafted cells was found to have migrated into the ventral root and a
small gap, thought to be due to fixation, was found between the ventral root and the cuff of
grafted rASCs.  The Schwann cells within the ventral root also moderately expressed GDNF
and BDNF (Fig. 5A and F).
Retrograde labelling studies, number of reinnervating motoneurons 
The number of retrogradely labelled motoneurons, i.e those cells that were able to send their
axons into the reimplanted ventral root correlated with the functional data.  Control animals
that had their ventral root avulsed and reimplanted and received untransfected rASC grafts
(group 1) had few reinnervating motoneurons (63 ± 4 SEM, n=5).  In contrast, in the spinal
cords  of  group  2  and  3  animals  which  received  a  GDNF-rASC  or  BDNF-rASC grafts,
respectively, much more retrogradely labelled motoneurons were found (192 ± 17 SEM vs
187 ± 12 SEM, n=5 each), without significant difference between these two groups (Fig. 6).
On the other hand, grafting of mixed populations of GDNF- and BDNF-rASCs around the
reimplanted  root  (group  4, n=5)  produced  slightly  improved  results:  The  numbers  of
reinnervating cells were 247 ± 24 SEM (Fig. 6). 
It is expected that reinnervating motoneurons regenerate their axons in an elongative growth
pattern  following  a  moderate  growth-promoting  stimulus.  Indeed,  axons  of  reinnervating
motoneurons  were  present  in  the  reimplanted  ventral  roots  in  both  control  and treatment
groups, although in differing numbers.  Ventral roots of control (group 1) animals contained
only few thin neurofilaments-stained fibres compared with the thicker and numerous axons of
the intact L4 ventral roots (Fig. 7A-B) while much more thin axons were found in the spinal
roots  of  group  2-4  animals  that  received  transfected  rASCs  (Fig.  7C-E).   We found  no
evidence of collateral sprouting of nerve fiber coil formation within the reimplanted roots
suggesting that the temporarily limited release of neurotrophins by the rASCs induced only
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elongative growth of regenerating axons (Fig. 7C-E).  Again, combined treatment with both
GDNF- and BDNF-rASCs induced no observable difference to treatments with these factors 
alone.
Analysis of choline acetyltransferase (ChAT) expression in injured and reinnervating
motoneurons 
Next the localization of ChAT-expressing surviving and Fast Blue-labelled reinnervating cells
was compared. In control rats  (group 1) the few retrogradely labelled motoneurons in the
ventral  horn  were  ChAT immunoreactive,  and  many ChAT immunoreactive  motoneurons
were found unlabelled with Fast Blue (Fig.  8A-C).  Stronger colocalization was found in
spinal cords of group 2-4 animals, who received transfected rASCs along their reimplanted
ventral root.  However, in these spinal cords there were still numerous ChAT immunoreactive
cells which were not retrogradely labelled (Fig. 8D-L). 
Accordingly, in control animals the proportions of Fast Blue-labelled motoneurons on the
operated side compared with that of the ipsilateral ChAT immunoreactive motoneurons were
17% ± 3 (SEM, group 1; Fig. 9) and only 5% ± 1 (SEM) of the total L4 motor pool was able
to reinnervate the target muscles.  In contrast, in animals that received  neurotrophic factor-
releasing  rASCs (group 2-4)  36-  to  50% of  the  total  motoneuron  pool  survived  (ChAT+
motoneurons) and 15- 20% of that was able to reinnervate (FB-labelled motoneurons, Fig. 9).
None of these three treatment groups were significantly different from each other in respect of
the proportion of FB+ and ChAT+ motoneuron numbers / total motoneuron pool, but they
were statistically different form the control group.
It is noted, that the reinnervating cells in these 3 groups comprised 15, 16, 20% of the intact
L4  motoneuron  pool  (100%  ±  14  SEM,  n=4),  suggesting  a  moderate  reinnervating
mechanism. On the other  hand, treatment  with transfected rASCs improved the ability of
surviving  motoneurons  to  reinnervate  peripheral  targets.   While  in  control  animals  only
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approx. 30% of the ChAT+ cells could send their axons into the reimplanted ventral root, in
group 2-4 animals this ratio was approximately 40% (Fig. 9).
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Discussion
Here  we  have  provided  evidence  that  a  spatiotemporally  controlled  expression  of  the
neurotrophic factors BDNF/ GDNF after ventral root avulsion and subsequent reimplantion of
the root promotes motoneuron survival and induces elongative axonal growth of the axons
with functional reinnervation of the target muscles. 
These effects were achieved by a) local application of the transgene-expressing mesenchymal
stem cells around the root, where only limited amounts of neurotrophic factors could reach the
growing  axons  and by  b)  a  temporally  regulated  expression  pattern.   This  is  due  to  the
intrinsic episomal nature of the plasmid resulting in a transient neurotrophic factor expression
pattern.
It has been well established that some neurotrophic factors, especially BDNF and GDNF have
a profound effect on motoneuron survival and axonal outgrowth. However, reinnervation of
the  peripheral  targets,  e.g.  skeletal  muscle  failed  in  the  studies  where  virus-based BDNF
and/or GDNF expression was induced in the spinal cord, ventral root or the peripheral nerve
pathways  (Blits  et  al.  2004,  Eggers  et  al.  2008,  2010).  Eggers  et  al.  (2013)  combined
neurosurgical reimplantation of avulsed ventral spinal roots with lentiviral vector-mediated
expression of GDNF in the reimplanted roots to create a neurotrophic factor gradient from the
reimplanted roots to the ventral spinal cord that would attract motor axons toward the root.
Lentiviral  vector  mediated over  expression  of  GDNF  prevents  motoneuron  death  and
enhances axonal outgrowth into reimplanted nerve roots. High locally applied concentrations
of GDNF caused trapping of growing axons and lead to coil formation (Eggers et al. 2008).
The same group has recently made efforts to create a gradient of GDNF in the sciatic nerve
after ventral  root avulsion and reimplantion using  lentiviral  vector-mediated expression of
GDNF.  Sprouting and  coil  formation  of  the  axons  was  observed  throughout  the  nerve
provided with  the  GDNF-gradient,  even at  relatively low concentrations  of  the  lentivirus
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applied. The size and number of coils increased with the level of GDNF expressed in the
peripheral nerve. Moreover, the number of Schwann cells was increased, but the myelination
of  the  axons  was  severely  impaired.  The  total  number  of  regenerated  and  surviving
motoneurons was not enhanced (Eggers et al. 2013).
On  the  other  hand,  intrathecal  administration  of  recombinant  GDNF  after  avulsion  and
reimplantation of the L4 ventral root into the spinal cord enhanced the survival rate of the
injured motoneurons, especially when it was applied in combination with riluzole (Bergerot et
al. 2004).  
There are several hypotheses why potent neurotrophic factors, like GDNF and BDNF rescued
the injured motoneurons but failed to promote the elongative growth of regenerating axons.
According to the widely accepted view on the mechanism of action of neurotrophic factors,
they provide a directional guidance for regenerating injured axons, which is readily observed
in  in  vitro experiments  (Tessier-Lavigne  and  Goodman,  1996).  The  failure  of  in  vivo
experiments in supporting elongative axonal growth was thought to be due to the high and
sustained neurotrophic factor concentrations around the axons.
The  possibility  that  axon  trapping  is  caused  by  a  different  mechanism  unrelated  to  the
neurotrophic effect of GDNF has been suggested, too. It is argued, that GDNF could have
direct effects on Schwann cells and on the interactions of Schwann cells with axons or on
myelination  (Hase  2005).  These  results,  however  have  clearly  shown  that  abundant  and
sustained application/overexpression of these neurotrophic factors may rather prevent axonal
regeneration after a successful initial phase of promoting of axon growth.
Several in vivo studies, mainly focusing on the regenerative effects induced by neurotrophic
factors  in the injured spinal cord have shown that transient expression of BDNF or GDNF
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significantly promoted the regenerative growth of injured axons (Blesch and Tuszynski 2007).
Boyd and Gordon (2002) have shown that low dose of exogenous BDNF (0.5±2 mg/day for
28 days)  promoted  axonal  regeneration  of  motoneurons  whose  regenerative  capacity  was
reduced  by  chronic  axotomy,  while  high  doses  of  BDNF  (12±20  mg/day  for  28  days)
significantly  inhibited  motor  axonal  regeneration,  after  both  immediate  nerve  repair  and
coaptation  following  chronic  axotomy.  The  dose-dependent  facilitation  and  inhibition  of
peripheral  nerve  regeneration with  exogenous BDNF could  be reversed by the  functional
blockade of BDNF receptors (Gordon and Boyd 2001, 2002). Taken together, these findings
suggested that  injured neurons are very sensitive to  the neurotrophic effect and the level,
gradient, duration and localization of neurotrophic factor expression all have a high impact on
regenerating injured axons (Anton et al. 1994, Bonner et al. 2010).
The question can be raised whether the relatively good functional recovery based on moderate
morphological reinnervation in the present study could be further improved.  In our earlier
studies  we  have  shown  that  administration  of  riluzole,  a  compound  capable  to  block
presynaptic release of glutamate and to inhibit voltage gated Na+ and Ca2+ channels induced
reinnervation of denervated hind limb muscles up to an extent of 67% after a ventral root
avulsion injury (Nógrádi and Vrbová 2001, Nógrádi et al. 2007).  In vitro evidence has also
been provided that riluzole is able to promote neurite growth of sensory ganglion neurons
(Shortland et al.  2006) further strengthening the neuroprotective effects of this compound.
Moreover, intraspinal or intraradicular transplantation of the neuroectodermal stem cell line
NE-FP-4C (ATCC No.: CRL-2936) resulted in similarly extensive reinnervation of the hind
limb muscles  after  the avulsion and reimplantation of  the L4 ventral  root  (Pajenda et  al.
2013).  It is possible that slightly more GDNF or BDNF secreted at the site of injury could
further improve the reinnervation by the surviving motoneurones. On the other hand, it could
be argued, that increased release of these neurotrophic factors would already induce a trapping
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effect on the regenerating axons, rather than supporting their elongative growth as seen in the
recent study by Eggers et al. (2013). 
It  was  interesting  to  find  that  the  combined  action  of  GDNF and  BDNF did  not  induce
significantly  improved  regeneration,  suggesting  that  the  combined  application  of  these
neurotrophic factors does not generate a synergistic effect in this model.
Further  studies  are  required  to  be  performed  in  order  to  elucidate  the  mechanisms  of
neurotrophic  factors on  injured  motoneurons  and  to  determine  the  dose  of  individual
neurotrophic factor that support survival and regeneration of injured motoneurons but do not
cause trapping of their regenerating axons.  Taking into consideration the extreme sensitivity
of these injured neurons to neurotrophic factors it appears likely that only very low doses,
applied to the indirect vicinity of the injured axons are able to fulfill these requirements.
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Figure 1: Schematic diagrams show the structure of pVAX1 vectors and the surgical
procedure
A-B: The structure of the pVAX1 vector backbone with the inserted therapeutic genes
C: Schematic drawing of the final result of the surgical procedure showing the reimplantation
of the L4 root and the localization of the rASCs embedded in collagen around the reimplanted
root.  Note the injured motoneurons (red) located in the ventral horn of the spinal segment.
D:  Schematic  drawing  showing  the  procedure  of  retrograde  labelling  of  regenerated
motoneurons with Fast Blue (blue) from the L4 spinal nerve three months after the avulsion
injury.
E: Microphotograph taken from the ventral horn of a spinal cord section where retrogradely
labelled  (blue)  and surviving (red)  motoneurons  are  located.  Arrowheads  point  to  double
labelled cells. Scale bar = 200 µm.
Figure  2:  ELISA-evaluated  production  of  GDNF  and  BDNF  by  transfected  and
untransfected cells in vitro
Bar charts show the time course of absolute gene expression (pg/ml) by the transfected cells
in vitro.  The untransfected cells produce no or negligible amounts of neurotrophic factors.
The transfected cells have a peak of neurotrophic factor production at 72h for BDNF and at
48h for GDNF, with a considerable decline after 5 days.  Note that the levels of neurotrophic
factors do not reach the 24h values from day 9 onwards. 
Figure 3: Biological activity of neurotrophic factors secreted by pVAX1_rBDNF- and 
pVAX1_mGDNF-transfected rASC cells. 
A: Neurite outgrowth of explanted and cultured E12.5 ganglion cells stimulated by the 
supernatant of untransfected rASCs. 
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B-D: Examples of in vitro longitudinal neurite outgrowth of rat embryonic dorsal root ganglia 
after 24 h in conditioned medium derived from pVAX1_rBDNF- or pVAX1_mGDNF-
transfected rASC cells. Scale bar = 250 μm.
E: Quantification of neurite outgrowth as fold change of the value of mock controls. Medium 
from untransfected cells induces limited outgrowth, whereas medium from pVAX1_rBDNF- 
and pVAX1_mGDNF-transfected rASCs increases neurite outgrowth twofold, respectively.  
Combined medium containing supernatants both from pVAX1_rBDNF- and pVAX1_mGDNF-
transfected rASCs does not produce augmented longitudinal neurite outgrowth.  Error bars: 
mean ± SEM, n = 6 per group. No significant difference was found among the groups treated 
with supernatants derived from transfected cells.  p < 0.05; one-way ANOVA followed by 
Bonferroni's post-hoc testing.
Figure 4. Results of the CatWalk automated gait analysis
The  gait  analysis  revealed  significant  differences  between  groups  1  (treatment  with
untransfected rASCs) and groups with various treatment strategies (groups 2-4). The earliest
significant differences in functional recovery between control and treatment groups appeared
from week 8 in case of most parameters.  Both the parameters indicating improved stability of
foot placing (max. contact area, print area, mean intensity, stance duration) and the improved
step cycle) suggested significant functional reinnervation in groups with neurotrophic factor
treatments. Note that the parameters of animals in groups 2-4 have significantly improved but
still  did  not  approach  the  pre-training  levels.  Asterisks  indicate  significant  differences
between groups 1 and 2-4 by using the two-way measurement analysis of variance (ANOVA)
computed  according  to  Tukey’s  all  pair-wise  multiple  comparison  procedures,  p  <  0.05.
(Symbols in the figure:  ♦ = untransfected rASC grafting,  ▲ = GDNF-rASC grafting, ▼ =
BDNF-rASC grafting,  ► = BDNF+GDNF-rASC grafting,  ■ = pre-training results)
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Figure 5.  Location and gene expression patterns of grafted rASCs.
A and F show GDNF- and BDNF-rASCs 10 days after transplantation around the reimplanted
ventral  root, respectively.  The cells appear as a tissue mass outside the connective tissue
sheath of the root (not labelled).  There is some GDNF and BDNF expression detected in
Schwann cells of the root itself. The rASCs labelled with CellBrite prior to grafting did not
migrate into the reimplanted root.  B-E and G-J (confocal images of the framed areas in  A
and F) indicate the protein expression pattern of grafted stem cells. Note that many, but not all
of the grafted cells are labelled with CellBrite and again, not all of them express GDNF or
BDNF.   Arrows point to cells that are both CellBrite+ and GDNF/BDNF+. Note that the
confocal images were obtained by the use of various optical thickness settings and they not
necessarily depict the same cell population as photographs taken from a thick section with
epifluorescence microscopy.  Scale bar in A,F  = 100 µm, in the rest of the figures = 20 µm.
Figure 6. Bar chart showing the results of retrograde labelling studies from the L4 spinal
nerve.  Transplantation of untransfected stem cells around the reimplanted ventral root (group
1)  resulted  in  low  number  of  retrogradely  labelled  motoneurons  in  the  L4  segment.
Transplantation of GDNF-rASCs, BDNF-rASCs or the combination of these two transfected
cell  types  (groups  2-4)  induced  considerable  reinnervation  of  the  reimplanted  root  (no
significant difference was found between these groups). * = significant difference between
groups 1 and groups 2-4, values are shown as mean +/- SEM. p < 0.01, t-test.
Figure 7.  Elongative growth of the regenerating axons in the reimplanted L4 ventral
roots.  The reimplanted ventral  roots taken from intact (A),  control (B) and neurotrophic
factor-treated (C-E) L4 ventral roots were sectioned and processed for 200kD neurofilament
immunohistochemistry.  In all samples elongative growth patterns were found, without signs
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for sprouting and coil formation.  Note the small number of regenerating axons in the root
treated with untransfected rASCs.  Scale bar = 50 µm.
Figure 8: Representative images of reinnervating and surviving motoneurons in the L4
spinal segment of rats treated with rASCs, 3 months after grafting.
A-C: Transverse sections of spinal cord taken from L4 spinal cord segment of an animal in
group  1  (untransfected  rASC  graft)  with  retrogradely  labelled  motoneurons  and  ChAT
immunereactive neurons, respectively. D-F: Spinal cord sections taken from a group 2 animal
(L4  ventral  root  avulsion  and  reimplantation  and  GDNF-rASC grafts).  G-I:  Spinal  cord
sections  taken from a  group 3  animal  (L4  avulsion  and reimplantation  and BDNF-rASC
graft).  J-L: Retrogradely labelled and surviving ChAT-positive cells in the L4 segment of a
group  4  animal  (combined  GDNF+BDNF-rASC  treatment).   Note  the  great  numbers  of
surviving (ChAT-positive) cells in the ventral horn at the operated side in D,G and J and the
relatively greater numbers of retrogradely labelled cells in the ventral horns of animals treated
with  transfected  rASCs  (E,H and  K).   There  is  a  striking  difference  in  the  numbers  of
surviving and reinnervating motoneurons between group 1 and groups 2-4 animals (note A-C
with few labelled motoneurons in the ventral horn). Surviving and reinnervating motoneurons
were  retrogradely  labelled  with  FB  and  the  same  sections  processed  for  ChAT
immunohistochemistry.  Arrowheads in C, F, I and L point to ChAT+ /FB- cells, while arrows
indicate ChAT+ only cells.  Note that due to the different objective depths used during taking
the photographs, some FB-labelled cells appear to express only faint ChAT.  Scale bars in A-B
= 200 µm , in C-N: 100  µm.
Figure 9.  Percentage of surviving motoneurons in the L4 ventral horn in various 
experimental paradigms.  Cholinacetyltransferase immunohistochemistry was applied to 
detect and determine the numbers of surviving motoneurons after ventral root avulsion and 
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reimplantation. Note that in control animals only limited number of motoneurons survived and 
even fewer had the chance to regenerate into the ventral root.  In groups 2-4 the higher 
surviving rate resulted in considerably better reinnervation rate. * and ** = significant 
difference between groups 1 and groups 2-4, values are shown as mean +/- SEM. p < 0.01, t-
test.
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